{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "Rooster Bogle came up to the rich Willamette Valley here from Texas as a migrant worker in 1961, already having served hard time in prison and with a habit of beating his wife and teaching his children to steal. Rooster, as Dale Vincent Bogle was known, taught them well. By the time the boys were 10 years old they were breaking into liquor stores for their dad or stealing tractor-trailer trucks, hundreds of them. The girls turned to petty crimes to support their drug addictions.", "headline": {"main": "Father Steals Best: Crime in an American Family"}, "abstract": "Observation that crime often runs in families is borne out by Oregon clan led by late Rooster Bogle; 28 members of clan have been arrested and convicted of various crimes; Justice Department figures show that 47 percent of inmates in state prisons have parent or other close relative who has also been incarcerated, and link between generations is so powerful that half of all juveniles in custody have father, mother or other close relative who has been in jail or prison; Oregon has introduced pioneering program of services for families of the imprisoned that tries to break cycle; chart of Bogle family's criminal convictions; photos (M)", "print_page": "1", "word_count": 1599, "_id": "4fd238968eb7c8105d7cb885", "snippet": "Rooster Bogle came up to the rich Willamette Valley here from Texas as a migrant worker in 1961, already having served hard time in prison and with a habit of beating his wife and teaching his children to steal.    Rooster, as Dale Vincent Bogle was...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/08/21/us/father-steals-best-crime-in-an-american-family.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "BOGLE, DALE VINCENT"}, {"name": "glocations", "value": "OREGON"}, {"name": "organizations", "value": "JUSTICE DEPARTMENT"}, {"name": "subject", "value": "CHILDREN AND YOUTH"}, {"name": "subject", "value": "CRIME AND CRIMINALS"}, {"name": "subject", "value": "FAMILIES AND FAMILY LIFE"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Fox", "lastname": "BUTTERFIELD"}], "original": "By FOX BUTTERFIELD"}, "document_type": "article", "pub_date": "2002-08-21T00:00:00Z", "section_name": "Front Page; U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "A federal judge has ordered the pharmaceuticals company GlaxoSmithKline to stop saying in its advertisements for Paxil, a top-selling antidepressant, that the drug is ''nonhabit-forming.'' The decision, which was issued Friday by Judge Mariana R. Pfaelzer of the United States District Court in Los Angeles but lawyers only talked about this week, was one of the first significant rulings on prescription drug advertising. It has caused the Food and Drug Administration, which regulates drug advertising, to file papers with the court, asking it to reconsider.", "headline": {"main": "Judge Orders Drug Company To Alter Ads", "kicker": "THE MEDIA BUSINESS: ADVERTISING"}, "abstract": "Federal Judge Mariana R Pfzelzer orders GlaxoSmithKline to stop saying in its advertisements for Paxil, top-selling antidepressant, that drug is 'nonhabit-forming'; decision is one of first significant rulings on prescription drug advertising; Food and Drug Administration has asked court to reconsider; agency says it has reviewed Paxil ads and agrees that drug company can make 'nonhabit-forming' claim; agency's lawyers says are concerned that decision, which is based in part on California law, can lead to situation where there could be different requirements for drug advertising in each of 50 states; lawsuit contends that GlaxoSmithKline did not warn patients of problems that could arise if they stopped taking Paxil; drawing (M)", "print_page": "1", "word_count": 672, "_id": "4fd21f898eb7c8105d7a269a", "snippet": "A federal judge has ordered the pharmaceuticals company GlaxoSmithKline to stop saying in its advertisements for Paxil, a top-selling antidepressant, that the drug is ''nonhabit-forming.''    The decision, which was issued Friday by Judge Mariana R....", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/08/21/business/the-media-business-advertising-judge-orders-drug-company-to-alter-ads.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "creative_works", "value": "ADVERTISING (TIMES COLUMN)"}, {"name": "persons", "value": "PFZELZER, MARIANA R"}, {"name": "glocations", "value": "CALIFORNIA"}, {"name": "organizations", "value": "FOOD AND DRUG ADMINISTRATION"}, {"name": "organizations", "value": "GLAXOSMITHKLINE"}, {"name": "subject", "value": "STATES (US)"}, {"name": "subject", "value": "ADVERTISING"}, {"name": "subject", "value": "MISLEADING AND DECEPTIVE ADVERTISING"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "SUITS AND LITIGATION"}, {"name": "subject", "value": "MENTAL HEALTH AND DISORDERS"}, {"name": "subject", "value": "PAXIL (DRUG)"}, {"name": "subject", "value": "LAW AND LEGISLATION"}, {"name": "subject", "value": "DEPRESSION (MENTAL)"}, {"name": "subject", "value": "DECISIONS AND VERDICTS"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Melody", "lastname": "PETERSEN"}], "original": "By MELODY PETERSEN"}, "document_type": "article", "pub_date": "2002-08-21T00:00:00Z", "section_name": "Health; Business"}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "Last month the government halted a major study of hormone replacement therapy in healthy women, saying the treatment under study seemed to do more harm than good. But while that action generated headlines and alarm, few people noticed just a few weeks earlier when the government decided not to go ahead with a different study of hormone replacement -- in older men. The hormone is testosterone, and its use is soaring. Doctors wrote 1.5 million prescriptions for testosterone and drugs like it in 2001, up from 806,000 in 1997. The hormone has been trumpeted as a possible antidote for aging and a way to get a lean and muscular body.", "headline": {"main": "Male Hormone Therapy Popular but Untested"}, "abstract": "Federal government decides not to press ahead with major study of hormone replacement therapy in older men, citing health risks; move follows discovery that testosterone can fuel growth of prostate cancer and increases red blood cell production, possibly increasing risk of clots that can cause heart attacks and strokes; hormone has been trumpeted as possible antidote for aging and way to get lean and muscular body; use is soaring; doctors wrote 1.5 million prescriptions for testosterone and drugs like it in 2001, up from 806,000 in 1997; experts say men taking drugs are participating in vast, uncontrolled medical experiment (M)", "print_page": "1", "word_count": 1668, "_id": "4fd222768eb7c8105d7a777e", "snippet": "Last month the government halted a major study of hormone replacement therapy in healthy women, saying the treatment under study seemed to do more harm than good. But while that action generated headlines and alarm, few people noticed just a few...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/08/19/us/male-hormone-therapy-popular-but-untested.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "HEART"}, {"name": "subject", "value": "HORMONES"}, {"name": "subject", "value": "MEN"}, {"name": "subject", "value": "TESTOSTERONE"}, {"name": "subject", "value": "PROSTATE GLAND"}, {"name": "subject", "value": "CANCER"}, {"name": "subject", "value": "AGED"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "TESTS AND TESTING"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Gina", "lastname": "KOLATA"}], "original": "By GINA KOLATA"}, "document_type": "article", "pub_date": "2002-08-19T00:00:00Z", "section_name": "Front Page; Health; U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "Money and Business/Financial Desk", "lead_paragraph": "WHEN Susan Houston needed a colonoscopy about five years ago, her doctor suggested doing the procedure in an operating room attached to his office. Before the procedure, she said, the doctor administered two shots -- one of Demerol, a narcotic painkiller, and one of Valium, a sedative. But Ms. Houston, 62, a psychoanalyst from New York, said the drugs did not work. ''I was wide awake through the whole thing,'' she said, recalling how she watched on the video monitor as the scope snaked through her intestine. ''It was painful; I had cramps. It was one of the most anxiety-producing experiences I've ever had.''", "headline": {"main": "In-Office Surgery: Fewer Rules Apply", "kicker": "MONEY & MEDICINE"}, "abstract": "Michelle Andrews Money & Medicine column notes outpatient surgeries and other medical procedures are increasingly performed in doctors' offices; only 10 states currently have any regulations governing office-based surgery; drawing (M)", "print_page": "9", "word_count": 867, "_id": "4fd220d48eb7c8105d7a4921", "snippet": "WHEN Susan Houston needed a colonoscopy about five years ago, her doctor suggested doing the procedure in an operating room attached to his office. Before the procedure, she said, the doctor administered two shots -- one of Demerol, a narcotic...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/08/18/business/money-medicine-in-office-surgery-fewer-rules-apply.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "REGULATION AND DEREGULATION OF INDUSTRY"}, {"name": "subject", "value": "SURGERY AND SURGEONS"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Michelle", "lastname": "ANDREWS"}], "original": "By MICHELLE ANDREWS"}, "document_type": "article", "pub_date": "2002-08-18T00:00:00Z", "section_name": "Health; Business"}, {"type_of_material": "News", "blog": [], "news_desk": "Money and Business/Financial Desk", "lead_paragraph": "FOR Dr. Rusty West, a physician at the Nocona Medical Clinic in Nocona, Tex., the free golf balls, dinners and sports tickets he had received over the years from drug companies were a ''small price to pay'' for access to him and the other doctors in his practice. But the trade group representing the pharmaceutical industry is now discouraging such gifts through a voluntary code of ethics that took effect in July. Though many other doctors seem to feel the same way as Dr. West, such guidelines from the Pharmaceutical Research and Manufacturers of America should come as no surprise. Offering gifts unrelated to a physician's practice -- a common way to gain access to a physician -- was explicitly discouraged in 1991 by ethics guidelines of the American Medical Association, to which roughly 30 percent of physicians belong. The Texas Medical Association, to which Dr. West belongs, also denounces such gifts. (Dr. West says that he has not been offered any perks lately, but that he had no ethical qualms about accepting them before.)", "headline": {"main": "Just Saying No to Gifts From Drug Makers", "kicker": "THE RIGHT THING"}, "abstract": "Jeffrey L Seglin The Right Thing column discusses Pharmaceutical Research and Manufacturers of America new voluntary code of ethics that bars gifts to doctors from drug manufacturers that are not for primary benefit of patients; holds doctors should have refused gifts in past; drawing (M)", "print_page": "4", "word_count": 805, "_id": "4fd26a528eb7c8105d821b92", "snippet": "FOR Dr. Rusty West, a physician at the Nocona Medical Clinic in Nocona, Tex., the free golf balls, dinners and sports tickets he had received over the years from drug companies were a ''small price to pay'' for access to him and the other doctors in...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/08/18/business/the-right-thing-just-saying-no-to-gifts-from-drug-makers.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "ETHICS"}, {"name": "subject", "value": "GIFTS"}, {"name": "subject", "value": "DOCTORS"}], "byline": {"person": [{"firstname": "Jeffrey", "middlename": "L.", "lastname": "SEGLIN", "rank": 1, "role": "reported", "organization": ""}], "original": "By JEFFREY L. SEGLIN"}, "document_type": "article", "pub_date": "2002-08-18T00:00:00Z", "section_name": "Health; Business"}, {"type_of_material": "News", "blog": [], "news_desk": "Magazine Desk", "lead_paragraph": "Globalization is a phenomenon that has remade the economy of virtually every nation, reshaped almost every industry and touched billions of lives, often in surprising and ambiguous ways. The stories filling the front pages in recent weeks -- about economic crisis and contagion in Argentina, Uruguay and Brazil, about President Bush getting the trade bill he wanted -- are all part of the same story, the largest story of our times: what globalization has done, or has failed to do. Globalization is meant to signify integration and unity -- yet it has proved, in its way, to be no less polarizing than the cold-war divisions it has supplanted. The lines between globalization's supporters and its critics run not only between countries but also through them, as people struggle to come to terms with the defining economic force shaping the planet today. The two sides in the discussion -- a shouting match, really -- describe what seem to be two completely different forces. Is the globe being knit together by the Nikes and Microsofts and Citigroups in a dynamic new system that will eventually lift the have-nots of the world up from medieval misery? Or are ordinary people now victims of ruthless corporate domination, as the Nikes and Microsofts and Citigroups roll over the poor in nation after nation in search of new profits?", "headline": {"main": "Globalization"}, "abstract": "Tina Rosenberg article proposes nine rules to make globalization more equitable, arguing that globalization is essential for development of third world but that it could be sabotaged because current rules do not let the poor share in benefits of growth; says that there must be role for government, that developing nations need technology transfers as well as assembly work, that there are worse evils that sweatshops, that intellectual-property rules of World Trade Organization, adopted as result of special-interest lobbying in US, should be eliminated, that US and other wealthy countries must stop dumping products on developing countries, that wealthy nations should drops rules that prevent poor countries from developing new exports and keep them dependent on commodities, that rich nations should open their work forces to temporary migrants, that International Monetary Fund should stop dictating economic policy to developing countries based solely on interests of global finance and that developing countries should have same kind of flexibility to achieve growth that served developed countries so well; photos (L)", "print_page": "28", "word_count": 7391, "_id": "4fd21eeb8eb7c8105d7a17dc", "snippet": "Globalization is a phenomenon that has remade the economy of virtually every nation, reshaped almost every industry and touched billions of lives, often in surprising and ambiguous ways. The stories filling the front pages in recent weeks -- about...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/08/18/magazine/globalization.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "INTERNATIONAL MONETARY FUND"}, {"name": "organizations", "value": "WORLD TRADE ORGANIZATION"}, {"name": "subject", "value": "COPYRIGHTS"}, {"name": "subject", "value": "FOREIGN LABOR"}, {"name": "subject", "value": "LABOR"}, {"name": "subject", "value": "INTERNATIONAL TRADE AND WORLD MARKET"}, {"name": "subject", "value": "DUMPING (TRADE TERM)"}, {"name": "subject", "value": "ECONOMIC CONDITIONS AND TRENDS"}, {"name": "subject", "value": "THIRD WORLD AND DEVELOPING COUNTRIES"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Tina", "lastname": "Rosenberg"}], "original": "By Tina Rosenberg"}, "document_type": "article", "pub_date": "2002-08-18T00:00:00Z", "section_name": "Magazine"}], "meta": {"hits": 6, "offset": 0, "time": 39}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}